Bayna Al Awani
Daman appoints new CFO
Abu Dhabi, August 21, 2013
Abu Dhabi-based National Health Insurance Company (Daman) has appointed Bayna Al Awani as its new chief financial officer (CFO).
Al Awani assumes responsibility for Daman’s financial management and control, legal affairs, insurance underwriting and procurement services; reporting to CEO Dr Michael Bitzer.
Daman’s chairman Khaled Al Qubaisi said: “Bayna has greatly impressed us during her time with Daman. She has always displayed great integrity and broad vision during her time with us which made her the logical choice to assume this key role within our management team. We are confident that she has the right talent and expertise to take on the role of CFO and will prove a real asset to Daman.”
“The development of Bayna’s leadership and management competencies over the past four years is a testament to the success of our Emiratisation plan which forms an integral part of our current and future strategy. We will continue to support and integrate the UAE National workforce into the growing field of health insurance,” he added.
Al Awani joined Daman in 2009 as director of Finance and has held senior finance positions in the oil and gas industry; bringing with her more than 15 years of experience.
“Working at Daman over the past few years has proven extremely rewarding, I am grateful for the opportunity to be part of such a forward-thinking and innovative company. I would like to thank the Board for their trust and affording me the opportunity to develop my career further,” Al Awani said. – TradeArabia News Service
More Health & Environment Stories
- Abu Dhabi to host mHealth summit
- DHA unveils roll out plan for health insurance
- Dubai hospital performs new pinhole surgery
- Al Ain Civil Defence ties up with disabilities centre
- ADWEA strategic partner for water summit
- Conference to focus on HSE issues
- Deadly human MERS virus also infects camels
- Axa Gulf launches medical provider locator
- Saudi medical devices market to hit $1.6bn
- Bahrain clamp on fitness drugs